Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

PLSE

Pulse Biosciences, Inc.

Healthcare · USD

Set alert

Price alert · PLSE

All alert types
52.24 USD -3.24 -5.84%
As of Oct 30, 2026 Extended hours 52.00 -0.46%
Bid
52.20 × 2
Ask
52.24 × 2
51.39 Day range 54.70
12.66 52-week range 55.48
YTD
+280.48%
1 year
+209.11%
Open
54.33
Prev close
55.48
Mkt cap
3.73B
Vol
466.45K
Avg vol
500.48K
EPS
-1.18
P/E
0.00
Div yield
0.00%
More statistics
Low
51.39
High
54.70
Forward P/E
-44.65
Beta
1.57
Short ratio
5.88
Inst. own
15.32%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
50.99
200-d avg
31.16
1y target
62.33

5D chart

Chart tools
Interval
1m5m15m30m
PLSE five-day price chart52.153.254.355.456.5Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

131.72 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 1

Valuation

P/E -12.7×
FY 2016: -7.6×FY 2017: -13.6×FY 2018: -5.2×FY 2019: -6.0×FY 2020: -11.1×FY 2021: -6.5×FY 2022: -1.6×FY 2023: -13.9×FY 2024: -18.9×FY 2025: -12.7×
FY 2016 5y median -12.7× FY 2025
P/S 2644×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 292×FY 2022: 134×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 2644×
FY 2016 5y median 134× FY 2025
P/B 11.5×
FY 2016: 2.8×FY 2017: 7.6×FY 2018: 3.0×FY 2019: 9.1×FY 2020: 24.2×FY 2021: 11.6×FY 2022: -41.8×FY 2023: 13.3×FY 2024: 8.9×FY 2025: 11.5×
FY 2016 5y median 11.5× FY 2025
P/FCF -17.0×
FY 2016: -8.8×FY 2017: -25.5×FY 2018: -8.1×FY 2019: -8.0×FY 2020: -15.5×FY 2021: -7.6×FY 2022: -2.0×FY 2023: -17.7×FY 2024: -27.9×FY 2025: -17.0×
FY 2016 5y median -17.0× FY 2025
EV/EBITDA -11.9×
FY 2016: -7.9×FY 2017: -14.0×FY 2018: -3.9×FY 2019: -5.9×FY 2020: -11.3×FY 2021: -6.3×FY 2022: -1.9×FY 2023: -13.9×FY 2024: -17.3×FY 2025: -11.9×
FY 2016 5y median -11.9× FY 2025
EV/Sales 2435×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 280×FY 2022: 155×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 2435×
FY 2016 5y median 155× FY 2025
FCF Yield -5.9%
FY 2016: -11.3%FY 2017: -3.9%FY 2018: -12.4%FY 2019: -12.5%FY 2020: -6.5%FY 2021: -13.2%FY 2022: -50.4%FY 2023: -5.6%FY 2024: -3.6%FY 2025: -5.9%
FY 2016 5y median -5.9% FY 2025

Profitability

Gross Margin -360.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -38.8%FY 2022: -1606.3%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -360.0%
FY 2016 5y median -38.8% FY 2025
Operating Margin -21982.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -4443.9%FY 2022: -8293.9%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -21982.6%
FY 2016 5y median -4443.9% FY 2025
Net Margin -20794.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -4489.4%FY 2022: -8357.9%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -20794.6%
FY 2016 5y median -4489.4% FY 2025
ROE -90.2%
FY 2016: -37.6%FY 2017: -55.6%FY 2018: -56.6%FY 2019: -149.6%FY 2020: -217.2%FY 2021: -178.4%FY 2022: 2602.5%FY 2023: -95.2%FY 2024: -46.7%FY 2025: -90.2%
FY 2016 5y median -90.2% FY 2025
ROIC -85.7%
FY 2016: -37.5%FY 2017: -54.2%FY 2018: -56.2%FY 2019: -128.0%FY 2020: -145.9%FY 2021: -134.2%FY 2022: -78.8%FY 2023: -81.4%FY 2024: -45.5%FY 2025: -85.7%
FY 2016 5y median -81.4% FY 2025
ROA -75.7%
FY 2016: -36.2%FY 2017: -51.3%FY 2018: -53.1%FY 2019: -109.7%FY 2020: -120.4%FY 2021: -117.3%FY 2022: -75.1%FY 2023: -71.4%FY 2024: -40.5%FY 2025: -75.7%
FY 2016 5y median -75.1% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -50.6%FY 2023: -100.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -36.8%
FY 2016: -114.6%FY 2017: -169.3%FY 2018: -47.1%FY 2019: -26.3%FY 2020: -4.2%FY 2021: -26.1%FY 2022: 7.9%FY 2023: 24.9%FY 2024: -29.1%FY 2025: -36.8%
FY 2016 FY 2025
EPS (diluted) -17.4%
FY 2016: -132.4%FY 2017: -101.2%FY 2018: -27.2%FY 2019: -0.9%FY 2020: 3.6%FY 2021: -6.5%FY 2022: 24.6%FY 2023: 48.8%FY 2024: -4.5%FY 2025: -17.4%
FY 2016 FY 2025
Free Cash Flow -49.3%
FY 2016: -138.5%FY 2017: -68.1%FY 2018: -77.2%FY 2019: -43.9%FY 2020: -2.9%FY 2021: -52.3%FY 2022: 13.1%FY 2023: 30.1%FY 2024: -10.0%FY 2025: -49.3%
FY 2016 FY 2025

Financial Health

Current Ratio 10.5×
FY 2016: 16.4×FY 2017: 17.4×FY 2018: 19.4×FY 2019: 5.9×FY 2020: 2.9×FY 2021: 4.3×FY 2022: 10.4×FY 2023: 6.8×FY 2024: 11.9×FY 2025: 10.5×
FY 2016 5y median 10.4× FY 2025
Quick Ratio 10.5×
FY 2016: 16.4×FY 2017: 17.4×FY 2018: 19.4×FY 2019: 5.9×FY 2020: 2.9×FY 2021: 3.6×FY 2022: 10.4×FY 2023: 6.8×FY 2024: 11.9×FY 2025: 10.5×
FY 2016 5y median 10.4× FY 2025
Debt / Equity 0.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.2×FY 2020: 0.5×FY 2021: 0.3×FY 2022: -33.8×FY 2023: 0.2×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 1.0×
FY 2016: 0.2×FY 2017: 0.1×FY 2018: 1.4×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.3×FY 2022: -0.3×FY 2023: 0.9×FY 2024: 2.1×FY 2025: 1.0×
FY 2016 5y median 0.9× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -97.5×FY 2022: -130×FY 2023: -39.6×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median -39.6× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31